Table 1 Descriptive statistics for men diagnosed with metastatic prostate cancer between 2005 and 2007 (N = 2,708)
N | % | |
|---|---|---|
Race/Ethnicity | ||
White non-Hispanic | 2096 | 77.4 |
African American non-Hispanic | 326 | 12.0 |
Hispanic | 159 | 5.9 |
Other | 127 | 4.7 |
Age | ||
66-69 | 375 | 13.9 |
70-74 | 499 | 18.4 |
75-79 | 555 | 20.5 |
80-84 | 645 | 23.8 |
85+ | 634 | 23.4 |
Married | 1583 | 62.3 |
Urban location | 2396 | 88.5 |
High PSA at baseline | 2298 | 84.9 |
Poorly differentiated tumor | 1638 | 60.5 |
Charlson Comorbidity Index | ||
Zero | 1453 | 53.7 |
One | 547 | 20.2 |
Two or higher | 470 | 17.4 |
Missing | 238 | 8.8 |
National Cancer Institute (NCI) Combined Index | ||
Zero | 1459 | 54.2 |
0-2 | 943 | 35.0 |
> = 2 | 53 | 2.0 |
Missing | 238 | 8.8 |
Bone metastasis | ||
Bone metastasis diagnosis | ||
SEER registry | 1694 | 62.6 |
Bone metastasis – related utilization | ||
Claims – BM Concurrent, Approach 1 | 1481 | 54.7 |
Claims – BM Concurrent, Approach 2 | 1363 | 50.3 |
Claims – BM Concurrent, Approach 3 | 1198 | 44.2 |